Sterling Pharmaceuticals Limited is a privately held limited company established in 2007, operating from its headquarters at 385 Moseley Rd, Moseley, Birmingham, B12 9DD. The company’s primary focus is the manufacture of pharmaceutical preparations, specializing in the development and production of a range of active pharmaceutical ingredients (APIs) and finished dosage forms. Sterling Pharmaceuticals operates within the broader pharmaceutical industry, encompassing a significant focus on the production of generic and custom-synthesized medications. The company’s core services include research and development, formulation, quality control, and regulatory compliance, ensuring adherence to stringent international standards. Currently, Sterling Pharmaceuticals Limited is active and maintains a significant international presence, though the extent of its global operations is currently assessed as ‘yes’. The company employs a skilled workforce, currently rated as a Worker (A rating), indicating a commitment to operational excellence. The company’s SIC codes include: - 21200: Manufacture of pharmaceutical preparations, - 40: Pharmaceutical manufacturing, - 41: Pharmaceutical research and development. The company’s website data indicates a focus on specialized API production and custom synthesis.

Sterling Pharmaceuticals Limited is a privately held limited company established in 2007, operating from its headquarters at 385 Moseley Rd, Moseley, Birmingham, B12 9DD. The company’s primary focus is the manufacture of pharmaceutical preparations, specializing in the development and production of a range of active pharmaceutical ingredients (APIs) and finished dosage forms. Sterling Pharmaceuticals operates within the broader pharmaceutical industry, encompassing a significant focus on the production of generic and custom-synthesized medications. The company’s core services include research and development, formulation, quality control, and regulatory compliance, ensuring adherence to stringent international standards. Currently, Sterling Pharmaceuticals Limited is active and maintains a significant international presence, though the extent of its global operations is currently assessed as ‘yes’. The company employs a skilled workforce, currently rated as a Worker (A rating), indicating a commitment to operational excellence. The company’s SIC codes include: - 21200: Manufacture of pharmaceutical preparations, - 40: Pharmaceutical manufacturing, - 41: Pharmaceutical research and development. The company’s website data indicates a focus on specialized API production and custom synthesis.